Medicare Enrolled
Dr. Dheeraj Kodali, M.D.
Hematology & Oncology · Stockton, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kodali from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kodali?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kodali
Dr. Dheeraj Kodali is a hematology & oncology specialist in Stockton, CA, with 15 years of NPI registration. Based on federal Medicare data, Dr. Kodali performed 23,372 Medicare services across 641 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kodali received a total of $4,711 from 49 pharmaceutical and/or device companies across 161 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kodali is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 22% volume in CA
$4,711 industry payments
Medicare Practice Summary
Medicare Utilization ↗23,372
Medicare services
Top 22% in CA for hematology & oncology
641
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,558 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
19,380 | $0 | $15 |
| Denosumab injection (Prolia/Xgeva) | 2,340 | $18 | $68 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
336 | $99 | $378 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
330 | $0 | $16 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
112 | $10 | $46 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
104 | $7 | $39 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
102 | $95 | $330 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
93 | $12 | $52 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
83 | $138 | $498 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
82 | $102 | $432 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
81 | $66 | $269 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
69 | $52 | $195 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
56 | $22 | $92 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
51 | $128 | $504 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
49 | $63 | $227 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
27 | $145 | $532 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
25 | $1,344 | $5,169 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
20 | $8 | $38 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 19 | $272 | $1,087 |
| New patient office visit, complex (60-74 min) | 13 | $150 | $705 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
83.8% high complexity
12.4% medium
3.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,711
Total received (2018-2024)
Avg $673/year across 7 years
Top 44% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
161
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,844 (81.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$867 (18.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,809
2023
$1,660
2022
$807
2021
$199
2020
$29
2019
$96
2018
$110
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$266
ABBVIE INC.
$155
E.R. Squibb & Sons, L.L.C.
$146
Celgene Corporation
$146
Genentech USA, Inc.
$119
Merck Sharp & Dohme LLC
$113
AstraZeneca Pharmaceuticals LP
$100
Lilly USA, LLC
$79
GlaxoSmithKline, LLC.
$63
SpringWorks Therapeutics, Inc.
$53
Astellas Pharma US Inc
$51
Incyte Corporation
$51
GENZYME CORPORATION
$37
Takeda Pharmaceuticals U.S.A., Inc.
$33
Stemline Therapeutics Inc.
$32
Sumitomo Pharma America, Inc.
$31
SOBI, INC
$31
Myriad Genetic Laboratories, Inc.
$31
Daiichi Sankyo Inc.
$29
Eisai Inc.
$29
Kite Pharma, Inc.
$28
Mirati Therapeutics, Inc.
$27
Ipsen Biopharmaceuticals, Inc
$27
Pharmacosmos Therapeutics Inc.
$25
Regeneron Healthcare Solutions, Inc.
$24
PUMA BIOTECHNOLOGY, INC.
$24
Octapharma USA, Inc.
$24
Exelixis Inc.
$23
Genmab U.S., Inc.
$13
Top 3 companies account for 31.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$367
AstraZeneca Pharmaceuticals LP
$316
Seagen Inc.
$314
E.R. Squibb & Sons, L.L.C.
$234
Kite Pharma, Inc.
$214
Takeda Pharmaceuticals U.S.A., Inc.
$203
Genentech USA, Inc.
$187
Celgene Corporation
$178
Lilly USA, LLC
$176
Incyte Corporation
$171
GlaxoSmithKline, LLC.
$168
Amgen Inc.
$159
ABBVIE INC.
$155
Janssen Biotech, Inc.
$155
SANOFI-AVENTIS U.S. LLC
$150
Monteris Medical Corporation
$140
GENZYME CORPORATION
$135
Merck Sharp & Dohme LLC
$135
AVEO Pharmaceuticals, Inc.
$102
Stemline Therapeutics Inc.
$83
Myriad Genetic Laboratories, Inc.
$73
ARRAY BIOPHARMA INC
$63
Daiichi Sankyo Inc.
$58
SpringWorks Therapeutics, Inc.
$53
Astellas Pharma US Inc
$51
Regeneron Healthcare Solutions, Inc.
$46
Mirati Therapeutics, Inc.
$44
TerSera Therapeutics LLC
$38
PFIZER INC.
$35
Medtronic, Inc.
$33
Karyopharm Therapeutics Inc.
$32
Sumitomo Pharma America, Inc.
$31
SOBI, INC
$31
Foundation Medicine, Inc.
$31
Myovant Sciences Inc.
$29
Eisai Inc.
$29
Ipsen Biopharmaceuticals, Inc
$27
Deciphera Pharmaceuticals Inc.
$26
Blueprint Medicines Corporation
$25
Pharmacosmos Therapeutics Inc.
$25
PUMA BIOTECHNOLOGY, INC.
$24
BeiGene USA, Inc.
$24
Octapharma USA, Inc.
$24
Exelixis Inc.
$23
Pharmacyclics LLC, An AbbVie Company
$22
Servier Pharmaceuticals LLC
$21
Gilead Sciences, Inc.
$21
SERVIER PHARMACEUTICALS LLC
$17
Genmab U.S., Inc.
$13
Top 3 companies account for 21.1% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · Alecensa · Avastin · BOSULIF · BRUKINSA · CABOMETYX · CALQUENCE · CHANTIX · COSELA · CYRAMZA · DARZALEX · ELITEK · EPKINLY · ERLEADA · Enhertu · Epkinly · FOTIVDA · Fabhalta · Gavreto · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · NINLARO · Neuroblate · Nplate · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · ONUREG · OPDIVO · ORGOVYX · OSTEOCOOL RF ABLATION SYSTEM · Onivyde · Orserdu · PADCEV · PRECISETUMOR · Padcev · Phesgo · Polivy · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · SARCLISA · SCEMBLIX · TAGRISSO · TIBSOVO · TUKYSA · Tecentriq · Tibsovo · Trodelvy · VENCLEXTA · VERZENIO · VONJO · XPOVIO · Yescarta · ZEJULA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (82%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
11
Per 100K population
1.4
County median income
$88,531
Nearest hospital
ST JOSEPH'S MEDICAL CENTER OF STOCKTON
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kodali is a mixed practice specialist, with above-average Medicare volume (top 22% in CA), with low-engagement industry engagement, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kodali experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Kodali performed 19,380 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kodali receive payments from pharmaceutical companies?
Yes. Dr. Kodali received a total of $4,711 from 49 companies across 161 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kodali's costs compare to other hematology & oncology specialists in Stockton?
Dr. Kodali's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kodali) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Stockton
Browse hematology & oncology specialists in Stockton ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology